What does APOTHEEK DE BUS do?

APOTHEEK DE BUS is a pharmacy in Dentergem. Public Limited, started on 30 December 1988, 1 establishment.

What is the address of APOTHEEK DE BUS?

The registered office of APOTHEEK DE BUS is located at Wapenplaats(Wak) 10, 8720 Dentergem.

Is APOTHEEK DE BUS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK DE BUS is active, legal situation “Normale toestand”, started on 30 December 1988.

Is APOTHEEK DE BUS registered on Peppol?

Yes, APOTHEEK DE BUS is registered on the Peppol network with ID 0208:0436343315.

What is the enterprise number of APOTHEEK DE BUS?

The enterprise number of APOTHEEK DE BUS is BE0436343315.

When was APOTHEEK DE BUS founded?

APOTHEEK DE BUS was founded on 30 December 1988.

Who are the directors of APOTHEEK DE BUS?

According to the 2025 annual accounts, the directors of APOTHEEK DE BUS are: Tagafar BV, Linafar BV.

Is APOTHEEK DE BUS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 1988; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK DE BUS make in 2025?

APOTHEEK DE BUS posted a profit after taxes of € 39,148 in financial year 2025.

What is the revenue of APOTHEEK DE BUS?

As a small company, APOTHEEK DE BUS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 161,544.

How many employees does APOTHEEK DE BUS have?

According to the 2025 annual accounts, APOTHEEK DE BUS has 0.5 full-time equivalents (FTE).

APOTHEEK DE BUS (Public Limited) - Dentergem

Dossier APOTHEEK DE BUS, printed on 30 October 2026 from databakkes.be/en/0436343315/apotheek-de-bus. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK DE BUS from Dentergem, company number BE0436343315, closed financial year 2025 with a result of € 39,148 after tax. For that financial year APOTHEEK DE BUS recorded a gross margin of € 161,544 and equity of € 551,836. Compared with financial year 2024, the result moved from € 79,406 to € 39,148. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 551,836

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 39,148

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 266,334

▲ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 15,000 paid out

38 % of the profit went to the shareholders, mostly to TAGAFAR (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 64,242

▲ 19% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 14 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 302,716

€ 20,900 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 97,411

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 10,998

▲ 19% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 163,207 Gross margin 2022: € 163,207 First fiscal year in the series	€ 229,191 Gross margin 2023: € 229,191 ▲ 40% vs 2022 (€ 163,207) Favourable step	€ 194,265 Gross margin 2024: € 194,265 ▼ 15% vs 2023 (€ 229,191) Unfavourable step	€ 161,544 Gross margin 2025: € 161,544 ▼ 17% vs 2024 (€ 194,265) Unfavourable step	▼ 17%
Profit after taxes	€ 17,866 Profit after taxes 2022: € 17,866 First fiscal year in the series	€ 104,193 Profit after taxes 2023: € 104,193 ▲ € 86,326 vs 2022 (€ 17,866) Favourable step	€ 79,406 Profit after taxes 2024: € 79,406 ▼ 24% vs 2023 (€ 104,193) Unfavourable step	€ 39,148 Profit after taxes 2025: € 39,148 ▼ 51% vs 2024 (€ 79,406) Unfavourable step	▼ 51%
Equity	€ 410,090 Equity 2022: € 410,090 First fiscal year in the series	€ 478,282 Equity 2023: € 478,282 ▲ 17% vs 2022 (€ 410,090) Favourable step	€ 527,688 Equity 2024: € 527,688 ▲ 10% vs 2023 (€ 478,282) Favourable step	€ 551,836 Equity 2025: € 551,836 ▲ 5% vs 2024 (€ 527,688) Favourable step	▲ 5%
Total debts	€ 480,266 Total debts 2022: € 480,266 First fiscal year in the series	€ 490,273 Total debts 2023: € 490,273 ▲ 2% vs 2022 (€ 480,266) Unfavourable step	€ 490,961 Total debts 2024: € 490,961 Unchanged (€ 490,273) Unfavourable step	€ 485,615 Total debts 2025: € 485,615 ▼ 1% vs 2024 (€ 490,961) Favourable step	▼ 1%
Cash	€ 179,878 Cash 2022: € 179,878 First fiscal year in the series	€ 237,996 Cash 2023: € 237,996 ▲ 32% vs 2022 (€ 179,878) Favourable step	€ 222,905 Cash 2024: € 222,905 ▼ 6% vs 2023 (€ 237,996) Unfavourable step	€ 266,334 Cash 2025: € 266,334 ▲ 19% vs 2024 (€ 222,905) Favourable step	▲ 19%
Land & buildings	€ 406,892 Land & buildings 2022: € 406,892 First fiscal year in the series	€ 386,261 Land & buildings 2023: € 386,261 ▼ 5% vs 2022 (€ 406,892) Unchanged	€ 379,680 Land & buildings 2024: € 379,680 ▼ 2% vs 2023 (€ 386,261) Unchanged	€ 381,606 Land & buildings 2025: € 381,606 ▲ 1% vs 2024 (€ 379,680) Unchanged	▲ 1%
Retained profit	€ 348,090 Retained profit 2022: € 348,090 First fiscal year in the series	€ 416,282 Retained profit 2023: € 416,282 ▲ 20% vs 2022 (€ 348,090) Favourable step	€ 465,688 Retained profit 2024: € 465,688 ▲ 12% vs 2023 (€ 416,282) Favourable step	€ 489,836 Retained profit 2025: € 489,836 ▲ 5% vs 2024 (€ 465,688) Favourable step	▲ 5%
Dividend	€ 10,000 Dividend 2022: € 10,000 First fiscal year in the series	€ 36,000 Dividend 2023: € 36,000 ▲ 260% vs 2022 (€ 10,000) Unchanged	€ 30,000 Dividend 2024: € 30,000 ▼ 17% vs 2023 (€ 36,000) Unchanged	€ 15,000 Dividend 2025: € 15,000 ▼ 50% vs 2024 (€ 30,000) Unchanged	▼ 50%
Bank debt	€ 335,441 Bank debt 2022: € 335,441 First fiscal year in the series	€ 319,410 Bank debt 2023: € 319,410 ▼ 5% vs 2022 (€ 335,441) Favourable step	€ 303,227 Bank debt 2024: € 303,227 ▼ 5% vs 2023 (€ 319,410) Favourable step	€ 302,716 Bank debt 2025: € 302,716 Unchanged (€ 303,227) Favourable step
Balance sheet total	€ 890,356 Balance sheet total 2022: € 890,356 First fiscal year in the series	€ 968,555 Balance sheet total 2023: € 968,555 ▲ 9% vs 2022 (€ 890,356) Unchanged	€ 1,018,649 Balance sheet total 2024: € 1,018,649 ▲ 5% vs 2023 (€ 968,555) Unchanged	€ 1,037,451 Balance sheet total 2025: € 1,037,451 ▲ 2% vs 2024 (€ 1,018,649) Unchanged	▲ 2%
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	0.5 Employees (FTE) 2023: 0.5 Unchanged (0.5) Unchanged	0.5 Employees (FTE) 2024: 0.5 Unchanged (0.5) Unchanged	0.5 Employees (FTE) 2025: 0.5 Unchanged (0.5) Unchanged

Key figures of APOTHEEK DE BUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK DE BUS?

What happened at APOTHEEK DE BUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Tagafar BV stepped down as director. NBB
2027 Linafar BV stepped down as director. NBB
Aug 31, 2026 New annual accounts for financial year 2025: profit of € 39,148 (▼ 51% vs 2024). filed late Source: NBB ↗
2021 Tagafar BV became a director. NBB
2021 Linafar BV became a director. NBB
Jan 26, 1989 New establishment in Dentergem. KBO
Dec 30, 1988 Start of the company according to the CBE. KBO

In short

From € 17,866 profit in 2022 to € 39,148 profit in 2025.

Paid € 47,571 in corporate taxes since 2022.

Best year ever: 2023, with € 104,193 profit.

Paid out € 91,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

TAGAFAR 50%

Linafar

The stake of TAGAFAR, Linafar comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DE BUS

The shares are held by TAGAFAR (50%) and Linafar.

Directors

According to the 2025 annual accounts

Tagafar BV

Director · represented by Ann De Bus

since 2021 · until 2027

Linafar BV

Director · represented by Lien De Bus

since 2021 · until 2027

Shareholders

TAGAFAR

50%

Linafar

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Wapenplaats(Wak) 10

8720 Dentergem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Linafar same network

€ 89,671 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0436.343.315

VAT number

BE 0436.343.315

Registered office

Wapenplaats(Wak) 10, 8720 Dentergem

Names & denominations

APOTHEEK DE BUS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 December 1988

Peppol

Active · Active since 30 Oct 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DE BUS

Financials

What happened to APOTHEEK DE BUS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions